Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity

Aim. To investigate differential beta-adrenoblocker (BAB) therapy, based on clinical and demographic characteristics of the patients, as a method to optimise the management of chronic heart failure (CHF).Material and methods. The study included 90 patients: 50 men (55,6%) and 40 women (44,4%) of mea...

詳細記述

書誌詳細

出版年:	Кардиоваскулярная терапия и профилактика
主要な著者:	S. N. Tereshchenko, I. V. Zhirov, A. V. Akinina, A. G. Kochetov
フォーマット:	論文
言語:	ロシア語
出版事項:	«SILICEA-POLIGRAF» LLC 2009-10-01
主題:	chronic heart failure beta-adrenoblockers brain natriuretic peptide aldosterone noradrenalin
オンライン･アクセス:	https://cardiovascular.elpub.ru/jour/article/view/1855